About this Research Topic
The aim of this Research Topic on “Demonstrating the Impact of IMI in Healthcare” is to provide a collection of articles demonstrating how IMI and other public-private partnerships supported by the European Union contribute to address major health challenges for the benefit of patients, industry and society.
To respond to this question, IMI projects cover all aspects of the innovation cycle leading to novel medicines or vaccines. This includes the development of new taxonomies of disease based on molecular profiling of patients driven by discovering new biomarkers. IMI projects also look at drug safety and links between genetic and environmental factors at play in complex disease states. Furthermore, a series of projects address key questions in the fight against infectious diseases, including antimicrobial resistance and the need for novel vaccines. As we increase our understanding of the interactions between the genome, the epigenome and the microbiome within each individual, a personalised or precision approach to medicine is made possible which has major ramifications on how we design clinical trials and driving the adoption of new regulatory pathways enabling more rapid access to patients of safe medicines in areas of unmet need. These steps cannot be developed any longer without embedding the participation of patients at all levels from project development right through to clinical use. Progress in stratification should also help to detect and intervene earlier in chronic diseases, contributing to increase health maintenance among the affected population. It is expected, in turn, that this early intervention will contribute to the affordability of the health systems.
Keywords: IMI, Healthcare, Treatment, Patients, Biomarkers
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.